HOLX News and Press, Hologic Inc. From 12/02/22

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Global Leader in Women’s Health Recognized with Three IMV ServiceTrak™ Awards for Mammography During RSNA 2022 Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, swept the 2022 IMV ServiceTrak™...

New Affirm® Contrast Biopsy Technology Included in the Screening, Diagnosis, Treatment and Monitoring Solutions on Display Hologic, Inc. (Nasdaq: HOLX) will exhibit its extensive portfolio of breast and skeletal health products at the 108 th Scientific Assem...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 5 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 2:40 p.m. Eastern Time. The fire-side chat presentation will be webcast live and may be accessed through a...

Summary Hologic exceeded expectations again on the back of stronger COVID-19 testing, but underlying diagnostics revenue was also strong. The pandemic greatly accelerated the adoption curve of the Panther diagnostics system, and it will be harder now for new systems to break into ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: What Moved Markets

3Dimensions System Earns Distinction for Meeting or Exceeding Rigorous European Image Quality and Dose Standards Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that its 3Dimensions™ mammography system was awarded EUREF Type...

Hologic ( NASDAQ: HOLX ) on Wednesday said it had got a $19M contract from the Biomedical Advanced Research and Development Authority (BARDA) to support research and development efforts. The funding will "help to bring Hologic’s Panther Fusion SARS-CoV-2/Flu A/...

Agency Awards $19 Million Contract to Fund Research and Development Hologic, Inc. (Nasdaq: HOLX) announced today that it has been awarded a $19 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to support research and development effort...

Hologic, Inc. ( NASDAQ: HOLX ) gained ~7% pre-market Tuesday as analysts issued favorable views on the COVID-19 test developer’s Q4 fiscal 2022 results that exceeded the company forecasts and the consensus. The company’s 2023 outlook which was in line w...